Month: February 2026

Sp Mortgage Bank Plc’s IFRS financial statements and Board of Directors’ report for 2025 have been published. Sp Mortgage Bank PlcStock Exchange Release12th of February 2026 at 8 am (CET +1) The materials are attached to this release and available in English and Finnish at www.saastopankki.fi. Sp Mortgage Bank Plc Further information: Tero Kangas, Managing Director Sp Mortgage Bank Plctero.kangas@saastopankki.fi+358 50 420 1022 Sp Mortgage Bank Plc is part of the Savings Banks Group and the Savings Banks Amalgamation. The role of Sp Mortgage Bank is, together with Central Bank of Savings Banks Finland Plc, to be responsible for obtaining funding for the Savings Banks Group from money and capital markets. Sp Mortgage Bank is responsible for the Savings Banks Group’s mortgage-secured funding by issuing covered bonds....

Central Bank of Savings Banks Finland Plc’s IFRS financial statements and Board of Directors’ report for 2025 have been published. Stock Exchange Release12th of February 2026 at 8 am (CET +1) The materials are attached to this release and available in English and Finnish at www.saastopankki.fi. Further information: Mervi Luurila, Managing Director Central Bank of Savings Banks Finland Plcmervi.luurila@saastopankki.fi+358 50 341 1196 Central Bank of Savings Banks Finland Plc is part of the Savings Banks Amalgamation and Savings Banks Group and operates as Group’s central credit institution. Central Bank of Savings Banks’ role is to ensure liquidity and wholesale funding of the Savings Banks Group via operating in the money and capital markets, issue payment cards, and provide payment transfer and account operator...

OSLO, Norway (12 February 2026) – TGS today reports interim financial results for Q4 2025. Financial highlights:Q4 Revenues of USD 363 million, driven by strong multi-client performance (sales-to-investment of 2.0x for the full year 2025) Solid order inflow of USD 598 million in Q4 2025 – total order backlog increased to USD 706 million Net cash flow of USD 206 million in 2025 Improved balance sheet resilience by reducing net debt by USD 73 million in 2025, to USD 427 million Stable dividend payment of USD 0.155 per share to be paid in Q1 2026 2026 guidance:Multi-client investment in the range of USD 500-575 million supported by strong customer commitments, up from USD 447 million in 2025 Significant increase in vessel utilization driven by high multi-client activity – OBN activity expected to be in-line with 2025 Gross...

Press ReleaseKaiseraugst (Switzerland), Maastricht (Netherlands), February 12, 2026 dsm-firmenich reports full year 2025 results Management Report 2025 highlightsGood financial performance, with strong contribution from synergies Strategic plan now fully executed following the announced divestment of Animal Nutrition & Health Animal Nutrition & Health has been classified as Assets Held for Sale and Discontinued Operations New €500 million share repurchase program to be launched in Q1 2026 Maintain stable dividend of €2.50 per share, adopting stable to preferably rising dividend policy Good progress in Sustainability, including EcoVadis Platinum and CDP double A for Climate & Water dsm-firmenich now ready for the next phase in its journey as a fully focused consumer company Investor Event scheduled for March 12, 2026Key...

FY 2025 sales growth of 10.9% at CER1, or 8.1% as reported, driven by growth of the three therapeutic areas of Oncology (4.1%1), Rare Disease (102.5%1) and Neuroscience (9.7%1); Somatuline® sales growth of 4.3%1, with all other products, excluding Somatuline, achieving double-digit sales growth of 14.2%1 FY 2025 core operating income of €1,294m, growing by 16.7% as reported, with a core operating margin of 35.2% of total sales, increasing by 2.6 points 2025 continued pipeline expansion, driven by significant regulatory and clinical milestones, integration of multiple preclinical assets with global rights and innovative approaches, and a mid-stage candidate from the acquisition of ImCheck Therapeutics Five major regulatory and clinical milestones expected in 2026, in addition to the full data readout for IPN10200 in an aesthetics indication Financial...

Regulated information Challenging 2025, with results in line with latest outlook, but significantly lower than initial expectations; Clear priorities set for 2026 to resume profit growth and improve cash generation, and strategic review initiatedFull year results in line with latest reviewed outlook:Revenue decreased by 4.9% LFL and adj. EBITDA margin by 2pp to 10%, on soft demand for baby care retailer brands and supply chain constraints; Net debt reduced by 6%, despite negative FCF, thanks to net proceeds from the completion of the Emerging Markets divestments, while leverage increased to 3.3x on lower adj. EBITDA; Recent challenges being addressed with clear priorities set for 2026 to resume volume growth, extend the cost transformation program, as well as laser focus on cash; Targeting adj. EBITDA growth of 10% in 2026, albeit gradually...

Sp Mortgage Bank Plc Stock Exchange Release12th February 2026 at 8 am (CET +1) Savings Banks Group’s Release of Financial Statements for 2025 has been published. Document containing the Financial Statements Release is attached to this release. The Financial Statements Release can be also found at www.saastopankki.fi. SAVINGS BANKS GROUP Additional information: Kai Koskela, CEO Savings Banks’ Union Coop kai.koskela@sastopankki.fi+358 40 549 0430  AttachmentSavings Banks Group’s Release of Financial Statements 2025

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 12 February 2026 – 7AM CET Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth and 10.9% increase in REBITDA Fagron, the leading global player in pharmaceutical compounding, today publishes its full year results for the period ending 31 December 2025. Key HighlightsStrong revenue growth with 9.2% reported growth (12.9% at CER1) to reach €952.2 million, ahead of guidance and supported by all regions and segments Organic growth at CER of 9.1% reflecting continued underlying demand and disciplined commercial execution Profitability increased with REBITDA up 10.9% YoY to €192.9 million, and REBITDA margin of 20.3%, supported by operating leverage and operational excellence initiatives Solid cash generation with operating cash flow of €155.3...

Central Bank of Savings Banks Finland Plc  Stock Exchange Release 12th February 2026 at 8 am (CET +1)  Savings Banks Group’s Release of Financial Statements for 2025 has been published.  Document containing the Financial Statements Release is attached to this release. The Financial Statements Release can be also found at www.saastopankki.fi.  SAVINGS BANKS GROUP  Additional information:  Kai Koskela, CEO Savings Banks’ Union Coop kai.koskela@sastopankki.fi+358 40 549 0430    AttachmentSavings Banks Group’s Release of Financial Statements 2025

HIAB CORPORATION, FINANCIAL STATEMENTS REVIEW 2025, 12 FEBRUARY 2026 AT 8:00 AM (EET) Hiab’s financial statements review 2025: Comparable operating profit margin continued to improve in 2025 Highlights of 2025Market environment was characterised by increased trade tensions and uncertainties Orders received remained at past two years’ level and amounted to EUR 1,481 (1,509) million Record high full year comparable operating profit margin of 13.7 (13.2) percent, despite 6 percent lower sales Record year in Services Strong cash generation continued, cash flow from operations before finance items and taxes totalled EUR 308 (582) million Hiab complemented its portfolio in Brazil with the acquisition of ING CranesThe figures in this financial statements review are based on Hiab Corporation’s audited 2025 financial statements. Unless...